ロード中...
COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy
Mackey and colleagues reported a systematic review that found high-certainty evidence that angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with greater illness severity in patients with COVID-19. The editorialist discusses the findings and emphasizes tha...
保存先:
| 出版年: | Ann Intern Med |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American College of Physicians
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7249506/ https://ncbi.nlm.nih.gov/pubmed/32422077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M20-3047 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|